CJC-1295 DAC (Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH 1-29) modified with a maleimido-propionyl group that covalently binds to serum albumin in the bloodstream. This “Drug Affinity Complex” dramatically extends the peptide’s half-life from minutes to 6-8 days, enabling once or twice weekly dosing.
Originally developed by ConjuChem Biotechnologies, CJC-1295 DAC produces a sustained elevation of growth hormone and IGF-1 levels rather than acute pulses. In clinical studies, a single injection increased mean GH levels 2-10 fold and IGF-1 levels 1.5-3 fold for 6-14 days.
The sustained GH elevation profile makes CJC-1295 DAC popular for anti-aging, body composition, and recovery goals — but the “always on” GH signal is a double-edged sword. Some prefer the pulsatile release pattern of CJC-1295 without DAC (also called Modified GRF 1-29), which more closely mimics natural GH secretion.
Looking for the best vendor deals?
Compare prices across 10+ peptide and anabolic vendors. Find the best quality at the lowest price.
Compare Vendors